Healthcare / Medical Care FacilitiesNYSE
$373.55
-4.99 (-1.32%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 22% · confianza 25%
FCF escenarios
weak_data · normalized FCF $5.6B · quality 81.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
45/100
C
Piotroski
7/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
20/100
SEC 0%
Sin guardar todavía.
Market Cap
$82.9B
P/E
12.9x
↓EV/EBITDA
8.8x
↓ROE
-112.6%
↓Gross Margin
41.5%
↓Debt/Equity
-8.08
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2009–2025 · 16 años de histórico normalizado
Revenue CAGR
—
FCF CAGR
+11.1%
FCF margin
10.2%
FCF / Net income
1.13x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $75.60B · net income $6.78B · FCF $7.69B
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||||||||
| Revenue | $75.60B | $75.60B | $70.60B | $64.97B | $60.23B | $58.75B | $51.53B | $51.34B | — | — | — | — | — | — | — | — | — | — |
| Net Income | $6.78B | $6.78B | $5.76B | $5.24B | $5.64B | $6.96B | $3.75B | $3.50B | $3.79B | $2.22B | $2.89B | $2.13B | $1.88B | $1.56B | $1.60B | $2.46B | $1.21B | $1.05B |
| EBITDA | $15.60B | $15.60B | $13.90B | $12.72B | $13.29B | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EPS | 28.33 | 28.33 | 22.00 | 18.97 | 19.15 | 21.16 | 10.93 | 10.07 | 10.66 | 5.95 | 7.30 | 4.99 | 4.16 | 3.37 | 3.49 | 4.97 | 2.76 | 2.44 |
| Gross Margin | 41.5% | 41.5% | 40.6% | 39.4% | 38.5% | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Operating Margin | 15.8% | 15.8% | 14.9% | 14.8% | 15.0% | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Margin | 9.0% | 9.0% | 8.2% | 8.1% | 9.4% | 11.8% | 7.3% | 6.8% | — | — | — | — | — | — | — | — | — | — |
| Balance Sheet | ||||||||||||||||||
| Debt/Equity | -8.08 | -8.08 | -18.10 | -23.60 | -14.53 | -36.81 | 53.84 | -11.96 | -6.47 | -4.83 | -4.27 | -3.98 | -3.68 | -3.34 | -2.85 | -3.11 | 2.32 | — |
| Current Ratio | 0.83 | 0.83 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Cash Flow | ||||||||||||||||||
| Free Cash Flow | $7.69B | $7.69B | $5.64B | $4.69B | $4.13B | $5.38B | $6.40B | $3.44B | $3.19B | $2.41B | $2.89B | — | $2.27B | $1.74B | $2.31B | $2.25B | $1.76B | $1.43B |
| Returns | ||||||||||||||||||
| ROE | -112.6% | -112.6% | -230.5% | -295.5% | -203.9% | -745.6% | 656.3% | -124.8% | -76.5% | -32.6% | -39.6% | -28.0% | -23.8% | -18.8% | -16.6% | -29.8% | 10.1% | — |
| Valuation | ||||||||||||||||||
| P/E | 12.87 | 12.87 | 13.49 | 14.54 | 13.29 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| EV/EBITDA | 8.79 | 8.79 | 8.71 | 9.21 | 8.60 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Growth & Yield | ||||||||||||||||||
| Revenue Growth | 7.1% | 7.1% | 8.7% | 7.9% | — | 14.0% | 0.4% | — | — | — | — | — | — | — | — | — | — | — |
| EPS Growth | 28.8% | 28.8% | 16.0% | -0.9% | — | 93.6% | 8.5% | -5.5% | 79.2% | -18.5% | 46.3% | 20.0% | 23.4% | -3.4% | -29.8% | 80.1% | 13.1% | — |
| Dividend Yield | 0.8% | 0.8% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
5.4%
EPS terminal req.
$33.15
Spread vs growth
23.4%
5Y implied EPS CAGR
7.2%
EPS terminal req.
$40.11
Spread vs growth
21.6%
10Y implied EPS CAGR
8.6%
EPS terminal req.
$64.59
Spread vs growth
20.2%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-1.2%
Start / end P/E
17.3x → 13.2x
EPS bridge
22.00 → 28.33
Residual
-6.9%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.